PEDRO
PÉREZ SEGURA
Profesor asociado de Ciencias de la Salud
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (7)
2023
-
What do patients and oncologists think about the evaluation and management of cancer-related anorexia-cachexia? The Quasar_SEOM study
Clinical and Translational Oncology, Vol. 25, Núm. 12, pp. 3479-3491
2014
-
Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)
Clinical and Translational Oncology, Vol. 16, Núm. 3, pp. 280-284
2012
-
Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)
Anti-Cancer Drugs, Vol. 23, Núm. 6, pp. 659-665
2011
-
Evidence for a link between TNFRSF11A and risk of breast cancer
Breast Cancer Research and Treatment, Vol. 129, Núm. 3, pp. 947-954
2009
-
Spanish society of medical oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients
Clinical and Translational Oncology, Vol. 11, Núm. 7, pp. 446-454
2008
-
Risk-reduction surgery in BRCA mutation carriers in a Spanish population: Adherence and results
Clinical and Translational Oncology, Vol. 10, Núm. 10, pp. 660-664
2005
-
The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families
Familial Cancer, Vol. 4, Núm. 2, pp. 183-186